AGP Ltd
AGP Ltd operates in Pharmaceuticals.
AGP Ltd (AGP) - Net Assets
Latest net assets as of June 2024: PKRs12.47 Billion PKR
Based on the latest financial reports, AGP Ltd (AGP) has net assets worth PKRs12.47 Billion PKR as of June 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (PKRs28.27 Billion) and total liabilities (PKRs15.81 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | PKRs12.47 Billion |
| % of Total Assets | 44.09% |
| Annual Growth Rate | 16.37% |
| 5-Year Change | 65.62% |
| 10-Year Change | N/A |
| Growth Volatility | 6.83 |
AGP Ltd - Net Assets Trend (2016–2023)
This chart illustrates how AGP Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for AGP Ltd (2016–2023)
The table below shows the annual net assets of AGP Ltd from 2016 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | PKRs12.36 Billion | +11.04% |
| 2022-12-31 | PKRs11.13 Billion | +9.54% |
| 2021-12-31 | PKRs10.16 Billion | +23.76% |
| 2020-12-31 | PKRs8.21 Billion | +10.02% |
| 2019-12-31 | PKRs7.46 Billion | +17.20% |
| 2018-12-31 | PKRs6.37 Billion | +15.55% |
| 2017-12-31 | PKRs5.51 Billion | +28.85% |
| 2016-12-31 | PKRs4.28 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to AGP Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 493.7% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | PKRs8.77 Billion | 76.65% |
| Other Components | PKRs2.67 Billion | 23.35% |
| Total Equity | PKRs11.44 Billion | 100.00% |
AGP Ltd Competitors by Market Cap
The table below lists competitors of AGP Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
LabTurbo Biotech Corporation
TWO:7725
|
$6.39K |
|
Viet Nam Forestry Corporation JSC
VN:VIF
|
$6.39K |
|
Fideicomiso Irrevocable F/2061 FHipo
MX:FHIPO14
|
$6.40K |
|
AALR3F
SA:AALR3F
|
$6.40K |
|
Rajoo Engineers Limited
NSE:RAJOOENG
|
$6.39K |
|
TRINITY MIRROR
BE:MRR
|
$6.38K |
|
Bayn Group AB (publ)
MU:B39
|
$6.38K |
|
MY XUAN BRICK
VN:GMX
|
$6.37K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in AGP Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 10,547,448,000 to 11,441,017,000, a change of 893,569,000 (8.5%).
- Net income of 1,565,109,000 contributed positively to equity growth.
- Dividend payments of 629,942,000 reduced retained earnings.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | PKRs1.57 Billion | +13.68% |
| Dividends Paid | PKRs629.94 Million | -5.51% |
| Other Changes | PKRs-41.60 Million | -0.36% |
| Total Change | PKRs- | 8.47% |
Book Value vs Market Value Analysis
This analysis compares AGP Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.54x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 9.42x to 4.54x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | PKRs19.68 | PKRs185.35 | x |
| 2018-12-31 | PKRs22.74 | PKRs185.35 | x |
| 2019-12-31 | PKRs26.65 | PKRs185.35 | x |
| 2020-12-31 | PKRs29.32 | PKRs185.35 | x |
| 2021-12-31 | PKRs34.56 | PKRs185.35 | x |
| 2022-12-31 | PKRs37.67 | PKRs185.35 | x |
| 2023-12-31 | PKRs40.86 | PKRs185.35 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently AGP Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 13.68%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.35%
- • Asset Turnover: 0.67x
- • Equity Multiplier: 2.45x
- Recent ROE (13.68%) is below the historical average (19.01%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 25.42% | 25.85% | 0.49x | 1.99x | PKRs659.38 Million |
| 2017 | 22.39% | 26.11% | 0.55x | 1.55x | PKRs682.81 Million |
| 2018 | 18.95% | 22.42% | 0.60x | 1.41x | PKRs569.93 Million |
| 2019 | 19.38% | 23.13% | 0.65x | 1.29x | PKRs700.10 Million |
| 2020 | 19.33% | 22.85% | 0.68x | 1.24x | PKRs766.39 Million |
| 2021 | 18.05% | 18.75% | 0.63x | 1.54x | PKRs779.43 Million |
| 2022 | 14.88% | 10.86% | 0.87x | 1.57x | PKRs515.20 Million |
| 2023 | 13.68% | 8.35% | 0.67x | 2.45x | PKRs421.01 Million |
Industry Comparison
This section compares AGP Ltd's net assets metrics with peer companies in the Pharmaceuticals industry.
Industry Context
- Industry: Pharmaceuticals
- Average net assets among peers: $19,660,601,500
- Average return on equity (ROE) among peers: 17.23%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| AGP Ltd (AGP) | PKRs12.47 Billion | 25.42% | 1.27x | $6.39K |
| Abbott Laboratories Pakistan Ltd (ABOT) | $13.24 Billion | 20.36% | 0.53x | $31.06K |
| The Searle Company Ltd (SEARL) | $26.09 Billion | 14.10% | 0.88x | $2.95K |